CEPA

A stably-priced, pre-enriched, anti-disease agent vector, live feed alternative to copepod, rotifer & artemia for fish & shrimp larvae in aquaculture hatcheries

  • Stage Prototype Ready
  • Industry Marine
  • Location Seville, Spain
  • Currency EUR
  • Founded July 2018
  • Employees 3
  • Incorporation Type Other

Company Summary

For sustainable aquaculture CEPA will produce selected nematodes as (i) an alternative pre-enriched live fish larvae feed (vs. copepod/rotifer/artemia) & (ii) a wild caught fish meal replacement. CEPA has US$570K, issued IP, POC data, including for fish disease control. For commercialization, CEPA seek US$350K short term, is in discussion with internationals re. licensing; & an 18 member industry/institute consortium for €8 million from the EU.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free